控制产前甲状腺筛查II:治疗母亲亚临床甲状腺功能异常对儿童行为的影响
CATS研究纳入475名母亲,评估治疗妊娠期亚最佳甲状腺功能(SGTF)对儿童行为的影响。结果显示SGTF与后代ADHD、ASD或行为问卷总分无总体关联,但过度治疗母亲(FT4>97.5百分位)的子代ADHD症状和行为困难显著多于正常甲状腺功能母亲。孕期甲状腺素补充需监测以避免过度治疗。
要点
- SGTF与后代ADHD、ASD或行为问卷总分无总体关联。
- 过度治疗母亲子代ADHD症状和行为困难显著增多。
- 孕期甲状腺素补充需监测以避免过度治疗。
核心结论
- SGTF与后代ADHD、ASD或行为问卷评分无总体关联,但过度治疗母亲子代ADHD症状和行为困难显著增多。
研究设计与样本
- CATS队列研究,475名母亲完成SDQ、儿童ADHD问卷和SCQ,儿童平均年龄9.5岁。
主要发现
- 正常甲状腺功能组(n=246)、治疗组(n=125)和未治疗组(n=104)的SGTF组间问卷总分无差异。
- 过度治疗母亲(n=40)子代SDQ品行问题(22% vs 7%)、SCQ总分(7% vs 1%)和ADHD多动(17% vs 5%)超过临床阈值比例高于未治疗组(N=100)。
- 过度治疗母亲子代SDQ品行问题评分(AMD 0.74;95%CI 0.021-1.431;P=0.040,效应量0.018)和ADHD多动评分(AMD 1.60;95%CI 0.361-2.633;P=0.003,效应量0.028)显著高于正常甲状腺功能母亲子代。
临床怎么用
- 孕期甲状腺素补充治疗SGTF时需监测甲状腺功能,避免过度治疗(FT4>97.5百分位)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT & OBJECTIVES: The Controlled Antenatal Thyroid Screening (CATS) study was the first randomized controlled trial to investigate effects of treating suboptimal gestational thyroid function (SGTF) on child cognition. Since observational studies indicated that SGTF may also increase symptoms of autism and attention-deficit/hyperactivity disorder (ADHD), the CATS cohort was used to investigate whether treatment of mothers affected their children's behavior. DESIGN & PARTICIPANTS: Mothers (N = 475) completed 3 questionnaires: the Strengths and Difficulties Questionnaire (SDQ), the Child ADHD Questionnaire, and the Social Communication Questionnaire (SCQ, used as a screen for autism spectrum disorder [ASD]), about their children (mean age 9.5 years). Group comparisons of total scores, numbers of children above clinical thresholds, and association between high maternal free thyroxine (FT4) (> 97.5th percentile of the UK cohort, "overtreated") and child neurodevelopment were reported. RESULTS: There were no differences in total scores between normal gestational thyroid function (GTF) (n = 246), treated (n = 125), and untreated (n = 104) SGTF groups. More children of treated mothers scored above clinical thresholds, particularly the overtreated. Scores were above thresholds in SDQ conduct (22% vs 7%), SCQ total scores (7% vs 1%), and ADHD hyperactivity (17% vs 5%) when comparing overtreated (n = 40) and untreated (N = 100), respectively. We identified significantly higher mean scores for SDQ conduct (adjusted mean difference [AMD] 0.74; 95% confidence interval [CI], 0.021-1.431; P = 0.040, effect size 0.018) and ADHD hyperactivity (AMD 1.60, 95% CI, 0.361-2.633; P = 0.003, effect size 0.028) comparing overtreated with normal-GTF children. CONCLUSIONS: There was no overall association between SGTF and offspring ADHD, ASD, or behavior questionnaire scores. However, children of "overtreated" mothers displayed significantly more ADHD symptoms and behavioral difficulties than those of normal-GTF mothers. Thyroxine supplementation during pregnancy requires monitoring to avoid overtreatment.
引用
- Hales C, Taylor PN, Channon S, et al. Controlled Antenatal Thyroid Screening II: Effect of Treating Maternal Suboptimal Thyroid Function on Child Behavior. J Clin Endocrinol Metab. 2020. PMID: 31665323. doi:10.1210/clinem/dgz098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。